IBDEI19N ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22431,1,4,0)
 ;;=4^346.40
 ;;^UTILITY(U,$J,358.3,22431,1,5,0)
 ;;=5^Migraine,Menstrual
 ;;^UTILITY(U,$J,358.3,22431,2)
 ;;=^336745
 ;;^UTILITY(U,$J,358.3,22432,0)
 ;;=346.30^^125^1392^78
 ;;^UTILITY(U,$J,358.3,22432,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22432,1,4,0)
 ;;=4^346.30
 ;;^UTILITY(U,$J,358.3,22432,1,5,0)
 ;;=5^Migraine,Hemiplegic
 ;;^UTILITY(U,$J,358.3,22432,2)
 ;;=^336744
 ;;^UTILITY(U,$J,358.3,22433,0)
 ;;=346.50^^125^1392^81
 ;;^UTILITY(U,$J,358.3,22433,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22433,1,4,0)
 ;;=4^346.50
 ;;^UTILITY(U,$J,358.3,22433,1,5,0)
 ;;=5^Migraine,Prst w/o Aura w/o Infarct
 ;;^UTILITY(U,$J,358.3,22433,2)
 ;;=^336746
 ;;^UTILITY(U,$J,358.3,22434,0)
 ;;=346.51^^125^1392^80
 ;;^UTILITY(U,$J,358.3,22434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22434,1,4,0)
 ;;=4^346.51
 ;;^UTILITY(U,$J,358.3,22434,1,5,0)
 ;;=5^Migraine,Prst w/ Aura w/o Infarct
 ;;^UTILITY(U,$J,358.3,22434,2)
 ;;=^336578
 ;;^UTILITY(U,$J,358.3,22435,0)
 ;;=346.70^^125^1392^77
 ;;^UTILITY(U,$J,358.3,22435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22435,1,4,0)
 ;;=4^346.70
 ;;^UTILITY(U,$J,358.3,22435,1,5,0)
 ;;=5^Migraine,Chr w/o Aura
 ;;^UTILITY(U,$J,358.3,22435,2)
 ;;=^336748
 ;;^UTILITY(U,$J,358.3,22436,0)
 ;;=780.72^^125^1392^93
 ;;^UTILITY(U,$J,358.3,22436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22436,1,4,0)
 ;;=4^780.72
 ;;^UTILITY(U,$J,358.3,22436,1,5,0)
 ;;=5^Quadraplegia,Functional
 ;;^UTILITY(U,$J,358.3,22436,2)
 ;;=^336672
 ;;^UTILITY(U,$J,358.3,22437,0)
 ;;=344.00^^125^1392^99
 ;;^UTILITY(U,$J,358.3,22437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22437,1,4,0)
 ;;=4^344.00
 ;;^UTILITY(U,$J,358.3,22437,1,5,0)
 ;;=5^Quadriplegia,Unspec
 ;;^UTILITY(U,$J,358.3,22437,2)
 ;;=^101908
 ;;^UTILITY(U,$J,358.3,22438,0)
 ;;=344.1^^125^1392^86
 ;;^UTILITY(U,$J,358.3,22438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22438,1,4,0)
 ;;=4^344.1
 ;;^UTILITY(U,$J,358.3,22438,1,5,0)
 ;;=5^Paraplegia NOS
 ;;^UTILITY(U,$J,358.3,22438,2)
 ;;=^90028
 ;;^UTILITY(U,$J,358.3,22439,0)
 ;;=907.2^^125^1392^74
 ;;^UTILITY(U,$J,358.3,22439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22439,1,4,0)
 ;;=4^907.2
 ;;^UTILITY(U,$J,358.3,22439,1,5,0)
 ;;=5^Late Effect of SCI
 ;;^UTILITY(U,$J,358.3,22439,2)
 ;;=^275240
 ;;^UTILITY(U,$J,358.3,22440,0)
 ;;=V12.54^^125^1392^72
 ;;^UTILITY(U,$J,358.3,22440,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22440,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,22440,1,5,0)
 ;;=5^Hx of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,22440,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,22441,0)
 ;;=438.10^^125^1392^14
 ;;^UTILITY(U,$J,358.3,22441,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22441,1,4,0)
 ;;=4^438.10
 ;;^UTILITY(U,$J,358.3,22441,1,5,0)
 ;;=5^CVA w/Language (late effect)
 ;;^UTILITY(U,$J,358.3,22441,2)
 ;;=^317906
 ;;^UTILITY(U,$J,358.3,22442,0)
 ;;=438.11^^125^1392^3
 ;;^UTILITY(U,$J,358.3,22442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22442,1,4,0)
 ;;=4^438.11
 ;;^UTILITY(U,$J,358.3,22442,1,5,0)
 ;;=5^CVA w/Aphasia (late effect)
 ;;^UTILITY(U,$J,358.3,22442,2)
 ;;=^317907
 ;;^UTILITY(U,$J,358.3,22443,0)
 ;;=438.13^^125^1392^6
 ;;^UTILITY(U,$J,358.3,22443,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22443,1,4,0)
 ;;=4^438.13
 ;;^UTILITY(U,$J,358.3,22443,1,5,0)
 ;;=5^CVA w/Dysarthria (late effect)
 ;;^UTILITY(U,$J,358.3,22443,2)
 ;;=^338239
 ;;^UTILITY(U,$J,358.3,22444,0)
 ;;=438.14^^125^1392^10
 ;;^UTILITY(U,$J,358.3,22444,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22444,1,4,0)
 ;;=4^438.14
 ;;^UTILITY(U,$J,358.3,22444,1,5,0)
 ;;=5^CVA w/Fluency (late effect)
 ;;
 ;;$END ROU IBDEI19N
